skip to main content

Pseudoephedrine sale restriction — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

HardPharmacy Law and EthicsPseudoephedrine sale restrictionGPhC CRA

A customer requests one product containing 60 mg pseudoephedrine and a separate product containing 15 mg ephedrine in the same transaction. Both quantities are below the individual statutory pack-content limits. What should the pharmacist do?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: EDecline the combination because pseudoephedrine and ephedrine products cannot be sold in one transaction

The restriction is transaction-specific: it is unlawful to sell a pseudoephedrine-containing product and an ephedrine-containing product together, even when each product is below its separate content ceiling. The individual limits of 720 mg pseudoephedrine and 180 mg ephedrine remain additional controls. These routine Pharmacy-medicine sales do not require a controlled-drug-register entry.

Reference: MHRA: Pseudoephedrine and ephedrine sales restrictions: https://www.gov.uk/drug-safety-update/pseudoephedrine-and-ephedrine-regular-review-of-minimising-risk-of-misuse-in-the-uk